Bluestone JA - Search Results

1

Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs.

Penaranda C, Tang Q, Ruddle NH, Bluestone JA. Penaranda C, et al. Among authors: bluestone ja. Diabetes. 2010 Jun;59(6):1461-8. doi: 10.2337/db09-1129. Epub 2010 Mar 18. Diabetes. 2010. PMID: 20299465 Free PMC article.

2

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction.

Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, Sgouroudis E, Piccirillo CA, Salomon BL, Bluestone JA. Tang Q, et al. Among authors: bluestone ja. Immunity. 2008 May;28(5):687-97. doi: 10.1016/j.immuni.2008.03.016. Epub 2008 May 8. Immunity. 2008. PMID: 18468463 Free PMC article.

3

Is antigen specificity of autoreactive T cells the key to islet entry?

Penaranda C, Bluestone JA. Penaranda C, et al. Among authors: bluestone ja. Immunity. 2009 Oct 16;31(4):534-6. doi: 10.1016/j.immuni.2009.09.006. Immunity. 2009. PMID: 19833083 Free article.

4

Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells.

Penaranda C, Tang Q, Bluestone JA. Penaranda C, et al. Among authors: bluestone ja. J Immunol. 2011 Aug 15;187(4):2015-22. doi: 10.4049/jimmunol.1100713. Epub 2011 Jul 8. J Immunol. 2011. PMID: 21742976 Free PMC article.

5

The role of CD28 and CTLA4 in the function and homeostasis of CD4+CD25+ regulatory T cells.

Boden E, Tang Q, Bour-Jordan H, Bluestone JA. Boden E, et al. Among authors: bluestone ja. Novartis Found Symp. 2003;252:55-63; discussion 63-6, 106-14. doi: 10.1002/0470871628.ch5. Novartis Found Symp. 2003. PMID: 14609212 Review.

6

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.

Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J, Masteller EL, McDevitt H, Bonyhadi M, Bluestone JA. Tang Q, et al. Among authors: bluestone ja. J Exp Med. 2004 Jun 7;199(11):1455-65. doi: 10.1084/jem.20040139. J Exp Med. 2004. PMID: 15184499 Free PMC article.

7

Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells.

Bluestone JA, Tang Q. Bluestone JA, et al. Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2(Suppl 2):14622-6. doi: 10.1073/pnas.0405234101. Epub 2004 Aug 20. Proc Natl Acad Sci U S A. 2004. PMID: 15322272 Free PMC article. Review.

8

Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice.

Masteller EL, Warner MR, Tang Q, Tarbell KV, McDevitt H, Bluestone JA. Masteller EL, et al. Among authors: bluestone ja. J Immunol. 2005 Sep 1;175(5):3053-9. doi: 10.4049/jimmunol.175.5.3053. J Immunol. 2005. PMID: 16116193

9

How do CD4+CD25+ regulatory T cells control autoimmunity?

Bluestone JA, Tang Q. Bluestone JA, et al. Curr Opin Immunol. 2005 Dec;17(6):638-42. doi: 10.1016/j.coi.2005.09.002. Epub 2005 Oct 4. Curr Opin Immunol. 2005. PMID: 16209918 Review.

10

Regulatory T-cell physiology and application to treat autoimmunity.

Tang Q, Bluestone JA. Tang Q, et al. Among authors: bluestone ja. Immunol Rev. 2006 Aug;212:217-37. doi: 10.1111/j.0105-2896.2006.00421.x. Immunol Rev. 2006. PMID: 16903917 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

537 results

Search Page

Filters